EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma

Zhe Cheng iD, Huichao Huang, Maoyu Li, Xujun Liang, Yuying Tan, Yongheng Chen iD

Pharmaceuticals · 25.04.2023 · 16 (5) · 644

DOI: 10.3390/ph16050644 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 25.04.2023. Verfasst von Zhe Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, NHC Key Laboratory of Cancer Proteomics, Laboratory of Structural Biology, National Clinical Research Center for Geriatric Di…. Die Arbeit wurde bisher 193-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hunan Provincial Science and Technology Department, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) is a malignant tumor associated with high morbidity and mortality. Therefore, it is of great importance to develop effective prognostic models and guide clinical treatment in HCC. Protein lactylation is found in HCC tumors and is associated with HCC progression.

Methods

The expression levels of lactylation-related genes were identified from the TCGA database. A lactylation-related gene signature was constructed using LASSO regression. The prognostic value of the model was assessed and further validated in the ICGC cohort, with the patients split into two groups based on risk score. Glycolysis and immune pathways, treatment responsiveness, and the mutation of signature genes were analyzed. The correlation between PKM2 expression and the clinical characteristics was investigated.

Results

Sixteen prognostic differentially expressed lactylation-related genes were identified. An 8-gene signature was constructed and validated. Patients with higher risk scores had poorer clinical outcomes. The two groups were different in immune cell abundance. The high-risk group patients were more sensitive to most chemical drugs and sorafenib, while the low-risk group patients were more sensitive to some targeted drugs such as lapatinib and FH535. Moreover, the low-risk group had a higher TIDE score and was more sensitive to immunotherapy. PKM2 expression correlated with clinical characteristics and immune cell abundance in the HCC samples.

Conclusions

The lactylation-related model exhibited robust predictive efficiency in HCC. The glycolysis pathway was enriched in the HCC tumor samples. A low-risk score indicated better treatment response to most targeted drugs and immunotherapy. The lactylation-related gene signature could be used as a biomarker for the effective clinical treatment of HCC.

Schlagwörter

Stichwörter der Autor:innen

hepatocellular carcinomalactylation-related genesprognostic modelprotein lactylationtreatment responsetumor immune environment

Autor:innen und Institutionen

  • Department of Oncology, NHC Key Laboratory of Cancer Proteomics, Laboratory of Structural Biology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008,…
  • Department of Infectious Disease, NHC Key Laboratory of Cancer Proteomics, Laboratory of Structural Biology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsh…

ORCID-Profile: Zhe Cheng, Yongheng Chen

Förderung

  • National Natural Science Foundation of China
  • Hunan Provincial Science and Technology Department
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of China
  • Youth Science Foundation of Xiangya Hospital
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Cheng, Z., Huang, H., Li, M., Liang, X., Tan, Y., & Chen, Y. (2023). Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma. Pharmaceuticals, 16(5), 644. https://doi.org/10.3390/ph16050644

Vancouver

Cheng Z, Huang H, Li M, Liang X, Tan Y, Chen Y. Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma. Pharmaceuticals. 2023;16(5):644. doi:10.3390/ph16050644

BibTeX
@article{Cheng2023,
  author = {Cheng, Zhe and Huang, Huichao and Li, Maoyu and Liang, Xujun and Tan, Yuying and Chen, Yongheng},
  title = {Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {5},
  pages = {644},
  doi = {10.3390/ph16050644}
}
Kostenlos starten →